Condition: Alzheimer's Dementia · Neuropsychiatric Symptoms Related to Neurodegenerative Disease · Wearable Devices · Sponsor: China Medical University Hospital
Taiwan is becoming a super-aged society, and more older adults are living with Alzheimer's disease. Many people with Alzheimer's experience behavioral and psychological symptoms, such as agitation, sleep problems, or mood changes. These symptoms often lower their quality of life and increase stress for their family caregivers. This study will test two wearable devices in people with Alzheimer's and their caregivers. One device, called Geneactiv, is a wristwatch that tracks daily activity and sleep. The other device, called Re-Timer, is a light therapy eyewear that may help improve sleep and mood. Researchers will look at how easy the devices are to use, whether participants are willing to wear them for several weeks, and whether the light therapy helps reduce sleep problems or caregiver stress. The study will also compare information from questionnaires with information collected by the devices. The results may help researchers design future studies using wearable tools to better support people living with dementia and their caregivers.
This description comes directly from the study's public registry record.
Dr Ta-Wei Guu Consultant psychiatrist, MD, PhD · 05783790 · 066753@tool.caaumed.org.tw
Yueh-Heng Chiang, RN, MS. · isyuehheng@gmail.com
Always discuss trial participation with your own doctor first.
| China Medical University Beigang Hospital | Beigang, Yunlin, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07249918